保守治疗的间歇性跛行患者疾病进展率与预测因素:系统综述
本系统综述纳入9项非随机队列研究共4115例保守治疗的间歇性跛行患者,随访平均5.4±2.72年,进展为慢性肢体威胁性缺血的比例为1.1-36.7%。Meta分析显示最大随访10年时合并进展率为15.26%(P=0.67),异质性99%(P<0.01)。糖尿病、吸烟和血液透析是多因素分析中的进展预测因素。
要点
- 保守治疗的间歇性跛行患者进展为慢性肢体威胁性缺血的比例为1.1-36.7%,随访平均5.4±2.72年。
- 合并进展率15.26%未达统计学显著(P=0.67),异质性99%(P<0.01),证据质量差且异质性大。
- 糖尿病、吸烟和血液透析是多因素分析中的进展预测因素。
核心结论
- 糖尿病、肾功能衰竭和吸烟是外周动脉疾病进展的重要预测因素。
- 证据质量差和数据异质性大妨碍得出进展率的确定性估计。
- 女性在研究中的代表性不足。
- 需要未来结构化的前瞻性预后研究来指导个体化管理策略。
研究设计与样本
- 系统综述(PROSPERO ID: CRD42023401259),遵循系统综述和Meta分析优先报告条目指南,检索Scopus、World of Science、Medline、Embase和CINAHL数据库。
- 纳入9项研究(7项回顾性队列和2项前瞻性队列),共4115例保守治疗的成人间歇性跛行患者。
- 进展率定义为随访期间发生慢性肢体威胁性缺血的患者百分比。
- 若研究显示同质性则计划进行定量合成。
- 所有纳入研究均为非随机队列设计,在确定因果效应方面存在预期局限性。
主要发现
- 检索获得6404份唯一报告,最终纳入9项研究共4115例患者。
- 女性平均占纳入患者的22.7%(范围0-30.1%)。
- 9项研究中5项偏倚风险评为「中等」,4项评为「严重」。
- 纳入研究的跛行患者中1.1-36.7%在随访结束时(平均5.4±2.72年)进展为慢性肢体威胁性缺血。
- Meta分析中最大随访(10年)时合并进展率为15.26%,未达统计学显著(P=0.67),异质性99%(P<0.01),可能不可靠。
关键数值与推荐
- 单因素分析中进展预测因素包括:高龄、糖尿病、血液透析、吸烟、血清低密度脂蛋白、HbA1c和基线缺血严重程度(踝肱指数、趾肱指数和跛行距离)。
- 多因素分析中进展预测因素为:糖尿病、吸烟和血液透析。
- 仅发现3项研究探讨外周动脉疾病进展的生物标志物。
临床怎么用
- 原文未据此给出推荐。
局限性
- 所有纳入研究均为非随机队列设计,在确定因果效应方面存在预期局限性。
- 9项研究中5项偏倚风险评为「中等」,4项评为「严重」。
- Meta分析合并进展率15.26%未达统计学显著(P=0.67),异质性99%(P<0.01),可能不可靠。
- 证据质量差和数据异质性大妨碍得出进展率的确定性估计。
- 女性在研究中的代表性不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intermittent claudication (IC) is a common pathology, affecting 4.5% of the United Kingdom population, and is associated with significant health burden if disease progresses to chronic limb-threatening ischemia (CLTI). The natural history of conservatively managed IC remains poorly described, and this study aimed to examine the rate and predictors of progression from IC to CLTI. METHODS: Systematic review (PROSPERO ID: CRD42023401259) in accordance with Preferred Reporting Items for Systematic reviews and Meta-analyses guidelines of available literature using Scopus, World of Science, Medline, Embase, and CINAHL databases. Adult patients with IC managed conservatively were included. Progression rate was defined as percentage of IC patients developing CLTI at follow-up. Predictors identified from univariate and multivariate analyses were included. A quantitative synthesis was planned if studies depicted homogeneity. RESULTS: Search terms yielded 6,404 unique reports. Nine studies (7 retrospective and 2 prospective cohorts) on a total of 4,115 patients were included in the primary synthesis. Women constituted 22.7% on average (0-30.1%) of patients included within studies. All included studies were nonrandomized cohort designs with expected limitations in terms of determining causal effect. The risk of bias was assessed as "moderate" in 5, and "serious" in 4 of the 9 included studies. 1.1-36.7% of claudicants from studies included developed CLTI by end of follow-up (mean 5.4 ± 2.72 years). A pooled progression rate of 15.26% at maximal (10 years) follow-up did not reach significance (P = 0.67) in meta-analysis and is likely unreliable, demonstrating 99% heterogeneity (P < 0.01). Predictors of progression were advanced age, diabetes, hemodialysis, smoking, serum low-density lipoprotein, HbA1c, and baseline severity of ischemia (Ankle-brachial index, Toe-brachial index and claudication distance) in univariate analysis. Diabetes, smoking and hemodialysis were predictors of progression in multivariate analysis. Only three studies investigating biomarkers of peripheral arterial disease (PAD) progression were found. CONCLUSIONS: Diabetes, renal failure, and smoking are significant predictors of PAD progression. Poor quality evidence and data heterogeneity preclude conclusive estimates of progression rates. Women are underrepresented among studies. Future structured, prospective prognostic studies addressing the progression of conservatively managed IC are needed to inform personalized management strategies.
引用
- Froud JLJ, Landin M, Wafi A, et al. Rate and Predictors of Disease Progression in Patients with Conservatively Managed Intermittent Claudication: A Systematic Review. Ann Vasc Surg. 2024. PMID: 39694186. doi:10.1016/j.avsg.2024.12.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。